Study of High-dose Influenza Vaccine Efficacy by Repeated Dosing In Gammopathy Patients
NCT02267733
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
51
Enrollment
OTHER
Sponsor class
Conditions
Influenza
Gammopathy
Interventions
DRUG:
Fluzone
Sponsor
Yale University